ThinkEquity Initiates Coverage on Beckman Coulter (BEC) with an Accumulate
ThinkEquity initiates coverage on Beckman Coulter (NYSE: BEC) with an Accumulate rating. Price target $60.
To see more analyst ratings on BEC Click Here.
Beckman Coulter, Inc. is a manufacturer and marketer of biomedical testing instrument systems, tests and supplies.
Related Categories
New CoverageStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
